Journal entry, "Hyperbaric oxygen therapy (HBOT) is involved with remission premiums [a period for the duration of which signs or symptoms of the ailment are lessened or disappear] of 81% to 85% at two to 3 yrs in patients with Continual refractory osteomyelitis." Carbonfree Qualified by ClimeCo certifies purchaser solutions waiting for link from Social Bookmarking (3)